Register a Pharmaceutical Company in Spain | Guide for UAE Entrepreneurs

Spain is emerging as one of the most attractive destinations to UAE entrepreneurs seeking to expand into the European pharmaceutical market. It is ideal to grow because of its access to the EU market, low operating expenses, well-regulated environment that is in line with EMA rules, and well-established R&D infrastructure. However, it is a complicated process to start a pharmaceutical business with the incorporation of corporate, registration of taxes, licenses and opening a bank account.

This guide will discuss how UAE investors may register a pharmaceutical company in Spain, giving simple steps and key insights to establish a fully compliant and successful pharmaceutical company in one of the most regulated and prospective markets in Europe.

Why Is Spain Attractive for UAE Pharmaceutical Entrepreneurs?

Spain is a major manufacturer and researcher of pharmaceuticals in the world and a significant pharmaceutical market in Europe. Spain has a number of strategic advantages for UAE-based entrepreneurs:

• Direct Access to the European Market
  A Spanish-based pharmaceutical company is free to conduct its operations in all EU member countries and grow very fast without having to register several legal entities.
• Strong and Transparent Regulatory Framework
  The pharmaceutical laws in Spain are completely in compliance with the European Medicines Agency (EMA) requirements, increasing their credibility in the global market and facilitating exports to Europe, Latin America, and other global markets.
• Competitive Operating Costs Within the European Union
  Compared to other key markets like Germany, France, or the Netherlands, Spain has competitive labour costs, cheap facilities leasing and low operational costs.
• Advanced R&D and Innovation Ecosystem
  The nation has well-established pharmaceutical clusters, research centres, and universities, as well as innovation centres, to assist in drug development, clinical trials and biotechnology projects.
• Strategic Location and Global Reach
  Spain is a point of entry to Europe, Latin America, and North Africa, and as such, an ideal location to base international pharmaceutical operations.

To UAE entrepreneurs seeking long-term expansion, Spain offers the optimal combination of affordability, regulatory stability, and international access to the market to develop a sustainable pharma business.

How to Register a Pharmaceutical Company in Spain from the UAE?

In order to establish a pharmaceutical company in Spain as a UAE-based entrepreneur, one has to go through two major steps:
(1) corporate incorporation and (2) pharmaceutical regulatory authorization. Both phases are required before starting operations.

Step 1: Choose the Legal Structure

An entrepreneur in the UAE has to choose the best legal form of business. The most popular options are:

• Sociedad Limitada (SL):
  Most suitable for small to medium-sized pharmaceutical businesses since it requires less capital and is easy to manage.
• Sociedad Anónima (SA):
  Ideal for larger pharmaceutical companies, manufacturing operations or businesses considering expansion or public investment in the future.

Alternatively, UAE investors can open a subsidiary or a branch office, according to their expansion strategy and operational requirements.

Step 2: Company Name Reservation

The name of the company selected should be registered at the Spanish Commercial Registry. This is to make sure the name is unique and can be registered legally.

Step 3: Open a Corporate Bank Account

The share capital of the company must be deposited in a corporate bank account in Spain or the EU. This step may be complicated because of strict compliance and verification conditions, and professional help is commonly suggested to non-resident UAE entrepreneurs.

Step 4: Company Incorporation

After opening the bank account, the incorporation documents are signed before a Spanish notary. This is then registered formally with the Commercial Registry, and it becomes a legal entity.

Step 5: Tax Registration

After incorporation, the company should:

• Obtain a Tax Identification Number (NIF)
• Register for corporate income tax
• Register for Value Added Tax (VAT), if applicable

This is done to make sure that the company is completely tax compliant in Spain.

Step 6: Pharmaceutical Licensing and Authorization

The company is required to get permission before starting pharmaceutical activities:

• The Spanish Agency of Medicines and Medical Devices (AEMPS)
• Relevant regional health authorities

The requirements of the licensing regulate different types of pharmaceutical activities, and they include technical documentation, inspection of facilities, and adherence to the EU requirements.

What Documents Do I Need to Start a Pharma Business in Spain?

UAE entrepreneurs have to create detailed documentation on company formation and compliance with regulations.

Corporate Documents

• Passports of shareholders and directors
• Proof of address
• Power of attorney (if representatives act on behalf of investors)
• Articles of association
• Shareholder structure details

Pharmaceutical & Regulatory Documents

• Detailed business plan
• Pharmaceutical activities description
• Technical layout and facility design
• Documentation of the quality management system
• Appointment of a qualified technical director
• GMP or GDP compliance documentation (if applicable)

All foreign-issued documents must be apostilled or legalized and officially translated into Spanish.

What Tax Incentives Are Available for the Pharmaceutical Business in Spain?

Spain provides one of the most favourable tax structures for the pharmaceutical business in Europe.

Key incentives include:

• Corporate Income Tax: Standard rate of 25%
• R&D Tax Credits: Up to 42% deduction on eligible R&D expenses
• Patent Box Regime: Lower taxation on intellectual property
• Innovation Deductions: This is applicable to a clinical trial and technological development
• Double Taxation Avoidance: Spain has agreements that are advantageous to foreign investors, including the UAE-based companies

Such incentives make Spain very attractive with regard to effective tax burden, and attract pharma businesses that require incentive of R&D.

What Pharmaceutical Activities Are Authorized and Regulated by AEMPS in Spain?

The Spanish Agency of Medicines and Medical Devices (AEMPS) is the national authority responsible for regulating pharmaceutical activities.

Authorized activities include:

• Pharmaceutical laboratories
• Manufacturing of active pharmaceutical ingredients (APIs)
• Import and export of medicinal products
• Sale of pharmaceuticals on a wholesale basis
• Plant of manufacture of medical devices
• Manufacturing and importing cosmetic
• Production, importation or storage of biocides
• The manufacture of personal care products

Each activity will need a particular license, and approval will be based on the technical infrastructure, personnel qualifications, and systems of compliance.

What Are the Licensing and Regulatory Requirements for Pharma Companies in Spain?

Licensing is the most important factor when venturing into the pharmaceutical business in Spain.

Core Regulatory Requirements

• Authorization from AEMPS
• Approval from regional health authorities
• Appointment of a qualified technical director
• Compliance with EU Good Manufacturing Practice (GMP)
• Adherence to Good Distribution Practice (GDP), where applicable
• Facility inspections prior to approval

The time of licensing depends on the activity and region, though it normally takes 3 to 12 months.

How Much Does It Cost to Register a Pharmaceutical Company in Spain?

The cost to register a pharma business in Spain depends on business scope, licensing complexity, and operational scale.

Estimated Cost Breakdown

• Company incorporation: €1,500 – €3,000
• Legal and advisory services: €5,000 – €15,000
• AEMPS licensing fees: €3,000 – €10,000+
• Qualified personnel and compliance systems: Variable

What Banking Challenges Do Foreign Pharmaceutical Companies Face in Spain?

The process of opening and maintaining a corporate bank account in Spain is usually among the most difficult for foreign pharmaceutical companies, particularly for non-EU investors like UAE entrepreneurs.

Key Banking Challenges

• Strict KYC and AML Compliance
  Spanish banks apply rigorous Know Your Customer (KYC) and Anti-Money Laundering (AML) checks. Foreign investors are required to present many documents regarding identity, source of capital and business activities.
• Enhanced Scrutiny of Pharmaceutical Activities
  The pharmaceutical business is considered a highly regulated industry, and it attracts extra compliance audits and extended approval periods.
• Non-Resident Ownership Restrictions
  The non-EU resident UAE entrepreneurs can be delayed or rejected, as a significant part of banks prefer firms with local directors or economic substance in Spain.
• Lengthy Account Approval Process
  The approval of corporate bank accounts may take a few weeks or even months, further delaying the company’s operations and licensing applications. 
• In-Person Verification Requirements
  Some Spanish banks require shareholders or directors to appear in person to complete the account-opening process.

Because of these difficulties, most of the foreign pharmaceutical companies use the services of specialized banking advisors or alternative EU financial institutions to open operational accounts.

Risks and Challenges for UAE Entrepreneurs in Spain’s Pharma Business Sector

Though there are great opportunities in Spain, UAE entrepreneurs should also know some of the risks and difficulties of entering the pharmaceutical market.

Regulatory and Licensing Delays

The licensing process of pharmaceuticals by AEMPS and the regional authority takes longer than predicted because of inspections, reviews of documents, and compliance.

High Compliance and Operational Costs

Maintaining GMP, GDP, and quality management systems involves ongoing expenses, including audits, inspections, and specialized personnel.

Language and Administrative Barriers

The majority of the regulatory communication and documentation is written in Spanish, and they may slow down without professional help on the site.

Regional Regulatory Differences

Spain’s autonomous communities have varying health regulations and inspection procedures, which can affect approval timelines and compliance obligations.

Banking and Financial Limitations

Ongoing banking restrictions, transaction monitoring, and payment processing delays may impact cash flow and supplier relationships.

Market Competition

Spain has a mature pharmaceutical market with strong domestic and international players, making differentiation and strategic positioning essential.

Conclusion

To UAE entrepreneurs, Spain is a country with a lot of opportunities to expand a pharmaceutical business with access to the EU, tax incentives, and internationally accepted regulatory standards. Licensing, compliance, and banking may be complicated, but with the right advice, it is an easy process. Ondemand International Dubai is a company specialized in assisting UAE investors to register a pharmaceutical company in Spain, including incorporation and regulatory approvals. Get started today and build your pharmaceutical company in Spain without fear.

FAQ’s